Serbia to Produce the Sputnik V Vaccine

The Russian Direct Investment Fund (RDIF) announced on March 25, 2021, the Republic of Serbia will become the first state in Southern Europe to produce the Sputnik V vaccine.

The Torlak Institute of Virology, Vaccines, and Serums will begin producing the vaccine in May 2021. The Torlak Institute is a state-owned manufacturer and supplier of vaccines to medical institutions in Serbia.

Nenad Popovic, Minister of Innovation and Technological Development, Co-Chairman of the Intergovernmental Committee for Cooperation between the Russian Federation and Serbia, noted in a press statement, "The production of the Sputnik V vaccine by the Torlak Institute will expand the capabilities of our country in the fight against coronavirus and open up new prospects for the supply of the vaccine to other countries of Southern Europe."

"The transfer of technology for the production of Sputnik V in Serbia will strengthen our sovereignty in the field of vaccine production. In the future, this area will be of great importance for every country ”.

The first batch of the Sputnik V vaccine was delivered to Serbia on December 30, 2020. Vaccination programs began in Serbia on January 6, 2021.

To date, the Sputnik V vaccine has been registered in 56 countries, stated the RDIF.